Login
Navigate Fool.com
Will SVA beat
the market?

Sinovac Biotech Ltd.

NASDAQ: SVA

Community Rating: 2 Stars: Unattractive

6.12 -0.01 (-0.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.12
Previous Close $6.13
Daily Range $6.02 - $6.32
52-Week Range $3.16 - $8.14
Market Cap $339.1M
P/E Ratio 47.15
Dividend (Yield) $0.00 (0.0%)
Volume 103,014
Average Daily Volume 576,863
Current FY EPS -$0.06

How do you think SVA
will perform against the market?

Top SVA Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted June 17, 2011

I can't say I exactly love this company, but I've been in and out a few times over the years for small gains and I haven't found anything else to rate today. Sinovac has an interesting lifetime stock … More

3 Replies Reply Report this Post
 

TMFBreakerBrian (< 20)
Submitted June 10, 2008

Any company garnering a positive rating from Dutton Associates should set off all sorts of warning bells to investors.

1 Replies Reply Report this Post

News & Commentary

Why Sinovac Biotech, Burlington Stores, and ZIOPHARM Oncology Are Today's 3 Best Stocks

The S&P makes up nearly all of yesterday's lost ground, while Sinovac, Burlington, and ZIOPHARM all rise by double digits.

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS Beat

Sector Update: Healthcare

Healthcare Stocks Nudge Higher; Sinovac Biotech Up 4% After Virus Vaccine Succeeds in Late-Stage Tes

Healthcare Stocks Nudge Higher; Sinovac Biotech Up 4% After Virus Vaccine Succeeds in Late-Stage Testing

Sector Update: Healthcare

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

Sector Update: Healthcare Shares Lower; Sinovac Surges 10% on Q3 Results

Sector Update: Healthcare

Why Sinovac Biotech Ltd. Shares Spiked Higher

Sinovac puts a thumping on the lone Wall Street earnings estimate in the second quarter, but are shares now overvalued?

Sector Update: Healthcare Shares Mixed Pre-Market; Sinovac Soaring 10% on Q2 Results

See More SVA News...

Sector

Healthcare

Industry

Drugs

Sinovac Biotech Ltd. (SVA) Description

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Website: http://www.sinovac.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks